{"id":"W3039421746","doi":"","title":"Résultats actualisés d’une l’étude de phase Ib/II chez des patients atteints de lymphome diffus à grandes cellules B (LDGCB) en rechute/réfractaire (R/R) traités par polatuzumab vedotin (Pola) plus bendamustine (B) et rituximab (R) ou obinutuzumab (G)","year":2019,"lang":"fr","type":"preprint","venue":"HAL (Le Centre pour la Communication Scientifique Directe)","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Canada Research Chairs; University of Toronto; McGill University; Okanagan University College; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Gynecology; Medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005524251,0.0008278606,0.001644175,0.0003759398,0.0007396449,0.001590953,0.000403489,0.001141013,0.003193488],"category_scores_gemma":[0.005571201,0.0004584647,0.001570166,0.0005910171,0.0008151485,0.0008472977,0.0004309484,0.001417133,0.001030328],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008841252,"about_ca_system_score_gemma":0.0006745884,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002791539,"about_ca_topic_score_gemma":0.001534736,"domain_scores_codex":[0.9974994,0.001143298,0.0002913031,0.0003413775,0.0004528608,0.0002717907],"domain_scores_gemma":[0.9957867,0.002091187,0.0004808157,0.0005529998,0.0008476504,0.0002405823],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.1942553,0.01468122,0.1298183,0.002420077,0.00454586,0.00204552,0.003909671,0.01207038,0.34781,0.0009610336,0.00608928,0.2813933],"study_design_scores_gemma":[0.02329498,0.2684464,0.3681862,0.0003888437,0.009058462,0.007003851,0.001241839,0.00543941,0.2372143,0.001241219,0.07820977,0.0002746863],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9747654,0.009007091,0.00576869,0.0003219078,0.0001486894,0.001138952,0.003356135,0.00007591391,0.005417134],"genre_scores_gemma":[0.9786131,0.002569307,0.003949831,0.0007476646,0.0001637297,0.001310486,0.00808969,0.00009291282,0.004463305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005524251,"threshold_uncertainty_score":0.02921534,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02032378919052187,"score_gpt":0.2869015229197112,"score_spread":0.2665777337291893,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}